Evidence map›Paper›PMID 25596303›Full record

ArticleThe Journal of infectious diseases2015

Interleukin 10-Dominant Immune Response and Increased Risk of Cutaneous Leishmaniasis After Natural Exposure to Lutzomyia intermedia Sand Flies.

Augusto M Carvalho, Juqueline R Cristal, Aline C Muniz, Lucas P Carvalho, Regis Gomes, José C Miranda, Aldina Barral, Edgar M Carvalho, Camila I de Oliveira

Abstract read
In one paragraph

Article in The Journal of infectious diseases, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Interventions for American cutaneous and mucocutaneous leishmaniasis.The Cochrane database of systematic reviews · 2020
    Pooled it
  2. Immune Response to LinB13, a Lutzomyia Intermedia Salivary Protein Correlates With Disease Severity in Tegumentary Leishmaniasis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Biomarkers for Zoonotic Visceral Leishmaniasis in Latin America.Frontiers in cellular and infection microbiology · 2018
    Review
  9. Analysis of the Antigenic and Prophylactic Properties of theFrontiers in cellular and infection microbiology · 2018
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Augusto M CarvalhoFundação Oswaldo Cruz, Centro de Pesquisas Gonçalo Moniz.
Juqueline R CristalFundação Oswaldo Cruz, Centro de Pesquisas Gonçalo Moniz.
Aline C MunizServiço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia.
Lucas P CarvalhoServiço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais.
Regis GomesFundação Oswaldo Cruz, Centro de Pesquisas Gonçalo Moniz.
José C MirandaFundação Oswaldo Cruz, Centro de Pesquisas Gonçalo Moniz.
Aldina BarralFundação Oswaldo Cruz, Centro de Pesquisas Gonçalo Moniz Instituto de Investigação em Imunologia, Salvador, Bahia, Brazil.
Edgar M CarvalhoServiço de Imunologia, Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia Instituto Nacional de Ciência e Tecnologia em Doenças Tropicais.
Camila I de OliveiraFundação Oswaldo Cruz, Centro de Pesquisas Gonçalo Moniz Instituto de Investigação em Imunologia, Salvador, Bahia, Brazil.

Funding

The role of Leishmania braziliensis strain polymorphism on disease outcome and ..P50AI030639 · NIAID · FEDERAL UNIVERSITY OF BAHIA · PI CARVALHO, EDGAR M · 1991 to 2023
$9.1M
NIAID NIH HHS AI 30639NIAID NIH HHS P50 AI030639
6 · The paper itself

Abstract

backgroundLeishmaniasis is caused by parasites transmitted to the vertebrate host by infected sand flies. During transmission, the vertebrate host is also inoculated with sand fly saliva, which exerts powerful immunomodulatory effects on the host's immune response.

methodsWe conducted a prospective cohort analysis to characterize the human immune response to Lutzomyia intermedia saliva in 264 individuals, from an area for cutaneous leishmaniasis (CL) caused by Leishmania braziliensis.

resultsAntibodies were found in 150 individuals (56.8%); immunoglobulin G1 and G4 were the predominant subclasses. Recall responses to salivary gland sonicate showed elevated production of interleukin 10 (IL-10), interleukin 13, interferon γ, CXCL9, and CCL2 compared with controls. CD4(+)CD25(+) T cells, including Foxp3(+) cells, were the main source of IL-10. L. braziliensis replication was increased (P < .05) in macrophages cocultured with saliva-stimulated lymphocytes from exposed individuals and addition of anti-IL-10 reverted this effect. Positive correlation between antibody response to saliva and cellular response to Leishmania was not found. Importantly, individuals seropositive to saliva are 2.1 times more likely to develop CL (relative risk, 2.1; 95% confidence interval, 1.07-4.2; P < .05).

conclusionsExposure to L. intermedia sand flies skews the human immune response, facilitating L. braziliensis survival in vitro, and increases the risk of developing CL.

Indexed as

Disease SusceptibilityAdolescentAdultAnimalsAntibodiesCD4-Positive T-LymphocytesChildChild, PreschoolCohort StudiesCytokinesFemaleHumansImmunoglobulin GInterleukin-10Leishmania braziliensisLeishmaniasis, CutaneousAntibodiesCytokinesImmunoglobulin GInterleukin-10chemokinescutaneous leishmaniasiscytokinesELISAkilling assayL. braziliensislutzomyia intermediasand fly saliva

Identifiers

PMID25596303
PMCPMC4539914

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.